Boehringer Ingelheim’s LastMile Initiative Touches Over 40,000 Smallholder Farmers In Africa
In partnership with GALVmed and Bill & Melinda Gates Foundation, Boehringer Ingelheim raises awareness of animal disease prevention and treatments among smallholder farmers in six African countries.
56 new Boehringer Ingelheim product registrations in eight countries across Africa support the livelihood of smallholder farmers
New product registrations increase the availability of veterinary medicine in the respective countries by 86 per cent.
LastMile, an initiative to train smallholder farmers in Africa on the prevention of animal diseases and leverage access to veterinary medicine, has reached more than 40,000 farmers in six countries.
The initiative aims to bridge the gap (“last mile”) in access, availability, and awareness of animal healthcare solutions in hard-to-reach areas. This improves productivity and income generation, hence ensuring food security and livelihood for the local communities.
LastMile, launched in 2018, is an initiative by Boehringer Ingelheim, in partnership with the Global Alliance for Livestock Veterinary Medicines (GALVmed) and funded by the Bill & Melinda Gates Foundation (BMGF).
It supports smallholder farmers in Kenya, Cameroon, Nigeria, Mali, Burkina Faso, and Ethiopia, and has enabled 56 product registrations in these countries as well as Uganda and Tanzania. By increasing the number of registered products, Boehringer Ingelheim facilitates access to more treatment options for farmers and veterinarians.
Tiago Teixeira, Project Lead for LastMile at Boehringer Ingelheim says.